Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Healthtrust
Citi
Deloitte
Chinese Patent Office
Novartis
Accenture
Federal Trade Commission
Medtronic

Generated: January 16, 2018

DrugPatentWatch Database Preview

Phentermine resin complex - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for phentermine resin complex and what is the scope of phentermine resin complex patent protection?

Phentermine resin complex
is the generic ingredient in three branded drugs marketed by Ucb Inc, Quantum Pharmics, and Lannett Holdings Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for phentermine resin complex. One supplier is listed for this compound.
Pharmacology for phentermine resin complex

US Patents and Regulatory Information for phentermine resin complex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics PHENTERMINE RESIN 30 phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 089120-001 Feb 4, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett Holdings Inc PHENTERMINE RESIN COMPLEX phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 040872-002 Jul 28, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lannett Holdings Inc PHENTERMINE RESIN COMPLEX phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 040872-001 Jul 28, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ucb Inc IONAMIN phentermine resin complex CAPSULE, EXTENDED RELEASE;ORAL 011613-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Covington
Colorcon
Accenture
Moodys
Baxter
Healthtrust
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot